Nabriva Therapeutics (NBRVF) Q2 2021 Earnings

5AugExpected
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-1.11
-0.84
-0.56
-0.29

Details

Expected EPS
-0.3467
Actual EPS
-0.29
Surprise EPS
0.06
Surprise Percent
+16.35%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.29 per share for Q2 2021.

0 Comments

Share your thoughts